Open company graph database — free web & API
Login

NANO Holdings Inc.

NANOホールディングス株式会社NANO MRNA Co., Ltd.AliasNANO MRNA Co.,Ltd.AliasNANO MRNA株式会社Former name
Ticker
Listed market
TYO
Country
Japan
Employees (non-consolidated)
20
Related companies
23
§01

Basic information

BASIC
Head office
6th Floor, NOVEL WORK Kanda, 2-10-4 Kanda Tsukasamachi, Chiyoda-ku, Tokyo
Chief executive
Shiro Akinaga
Capital
90,000,000
Employees (non-consolidated)
20 people
Employees (consolidated)
Start date
2026-04-01
End date
§02

Websites

1 DOMAINS
§03

Business

2
mRNA Drug Discovery BusinessSales Business
§04

Related companies

23 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
PrimRNA Inc.
Group
JCR Pharma Corporation
Group
Luna RD Corporation
Group Customer Alliance
Micropore Technologies Ltd
Group
NANO HOLDINGS
Group
NANO Holdings Inc.
Group
PrimRNA AU Pty. Ltd.
Group
セオリアファーマ
Supplier
京都大学
Alliance
京都府立医科大学
Alliance
Hokkaido University Co-op
Alliance
名古屋大学
Alliance
名古屋市立大学
Alliance
大阪医科薬科大学
Alliance
Osaka University
Alliance
Hiroshima University
Alliance
Keio University
Alliance
東京医科歯科大学
Alliance
University of Tokyo
Alliance
Tokyo University of Science
Alliance
Institute of Science Tokyo
Alliance
Kanazawa University
Alliance
静岡県立大学
Alliance
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

2 EVENTS

Established: April 2021 (Reiwa 3)Sources

Started as a new subsidiary, NANO MRNA Inc., under NANO HoldingsSources

§07

News

3 ARTICLES

NANO Holdings 2026 Conference and Exhibition InformationSources

NANO Holdings plans to present research and hold seminars on oligonucleotides and mRNA pharmaceuticals at academic conferences and meetings scheduled for July 2026.

Introduction of NANO Holdings' Pipeline 'TUG1 ASO'Sources

Our 'TUG1 ASO' was featured in Nikkei Biotechnology Online, supported by AMED's 2026 fiscal year adjustment funds.

Nano Holdings' Clinical Trials and International Conference Participation StatusSources

Subsidiary PrimRNA participated in international conferences in Australia and Singapore, sharing developments in disease-modifying drugs and RNA drug discovery technologies.

§08

Public records

GOV
National Tax Agency basic information5040001067344
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
NANOホールディングス株式会社
Trade name (kana)
ナノホールディングス
Name in English
Corporation type
301
Address
〒105-0002 東京都港区愛宕2丁目5番1号
Postal code
1050002
Prefecture code
13
City code
103
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2025-12-19
Change date
2025-12-12
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
11
Correction type
0
Trade name image ID
Address image ID
Sequence number
2010574
METI gBizINFO5040001067344
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
5040001067344
Trade name
NANOホールディングス株式会社
Trade name (kana)
ナノホールディングス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
東京都港区愛宕2丁目5番1号
Postal code
1050002
Prefecture
東京都
Prefecture code
13
City or district
港区
City code
103
Street address
愛宕2丁目5番1号
Organisation type
301
Processing type
11
Correction type
0
Status
Representative
代表取締役会長兼社長CEO 松村 淳
Capital
979046000
Employees
28
Employees (male)
10
Employees (female)
11
Business summary
医薬品などの研究開発および製造
Website URL
https://www.nanocarrier.co.jp
Year founded
Business category
E:製造業
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2025-12-19
Key information
5040001067344
§09

Sources & updates

SOURCES
↑